Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This artificial peptide mimics the actions of naturally produced GLP-1, a https://rotatesites.com/story22309565/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes